Serum interleukin-6 as a biomarker of disease activity and severity in chronic spontaneous urticaria: a case control study in urban south Indian population
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20252549Keywords:
CSU, Cytokines, IL-6, UAS7Abstract
Background: Chronic spontaneous urticaria (CSU) is a challenging dermatological condition marked by recurrent wheals lasting over six weeks without identifiable triggers. While its pathogenesis is not fully understood, emerging evidence suggests a role for pro-inflammatory cytokines, particularly interleukin-6 (IL-6), in disease activity. However, its relevance as a biomarker for disease severity remains to be clarified. To evaluate serum IL-6 levels in CSU patients and determine their correlation with disease severity, compared to healthy controls.
Methods: A case-control study was conducted in the Department of Dermatology at Raja Rajeswari Medical College and Hospital from April 2023 to September 2024. Fifty CSU patients and fifty age- and sex-matched healthy controls were enrolled. Disease severity was assessed using the Urticaria Activity Score over 7 days (UAS7). Serum IL-6 levels were measured using ELISA. All calculations were performed using Statistical Package for the Social Sciences (SPSS) version 20 (SPSS Inc., Chicago).
Results: Most CSU patients (66%) were young adults (20–40 years), with equal gender distribution. Severe disease (UAS7: 16–42) was observed in 72% of patients. Mean IL-6 levels were significantly higher in CSU patients than in controls (9.1±5.1 vs. 3.12±2.8 pg/ml, p=0.004). IL-6 levels showed a significant positive correlation with disease severity.
Conclusions: Serum IL-6 is significantly elevated in CSU patients and correlates with disease severity. It may serve as a promising biomarker for monitoring disease activity and tailoring treatment in CSU, warranting further investigation into its therapeutic potential.
Metrics
References
Zuberbier T, Aberer W, Asero R. The EAACI/GA²LEN/EDF/WAO Guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73(7):1393-414. DOI: https://doi.org/10.1111/all.13397
Maurer M, Weller K, Bindslev-Jensen C. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report. Allergy. 2011;66(3):317-30. DOI: https://doi.org/10.1111/j.1398-9995.2010.02496.x
Dice JP. Physical urticarias. Immunol Allergy Clin North Am. 2004;24(2):225-46. DOI: https://doi.org/10.1016/j.iac.2004.01.005
Kolkhir P, Balakirski G, Magerl M, Zuberbier T, Church MK, Maurer M. Comorbidity of chronic spontaneous urticaria and autoimmune thyroid diseases: A systematic review. Autoimmun Rev. 2016;15(12):1246-54.
Kasperska-Zajac A, Grzanka A, Damasiewicz-Bodzek A. IL-6 transsignaling in patients with chronic spontaneous urticaria. PLoS One. 2015;10(12):145751. DOI: https://doi.org/10.1371/journal.pone.0145751
Takahagi S, Mihara S, Iwamoto K. Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy. 2010;65(5):649-56. DOI: https://doi.org/10.1111/j.1398-9995.2009.02222.x
Fujii K, Konishi K, Kanno Y, Ohgou N. Acute urticaria with elevated circulating interleukin-6 is resistant to anti-histamine treatment. J Dermatol. 2001;28(5):248-50. DOI: https://doi.org/10.1111/j.1346-8138.2001.tb00126.x
Atwa MA, Emara AS, Youssef N, Bayoumy NM. Serum concentration of IL-17, IL-23 and TNF-α among patients with chronic spontaneous urticaria: association with disease activity and autologous serum skin test. J Eur Acad Dermatol Venereol. 2014;28(4):469-74. DOI: https://doi.org/10.1111/jdv.12124
Kuna M, Štefanović M, Ladika Davidović B, Mandušić N, Birkić Belanović I, Lugović-Mihić L. Chronic Urticaria Biomarkers IL-6, ESR and CRP in correlation with disease severity and patient quality of life-a pilot study. Biomedicines. 2023;11(8):2232. DOI: https://doi.org/10.3390/biomedicines11082232
Godse K, Patil A, De A, Sharma N, Rajagopalan M. Diagnosis and Management of Urticaria in Indian Settings: Skin Allergy Research Society's Guideline-2022. Indian J Dermatol. 2022;67(6):732-43. DOI: https://doi.org/10.4103/ijd.ijd_307_22
Datta S, De A, Singh S, Sarda A, Dhar S. Biomarkers of chronic spontaneous urticarial. Indian J Skin Allergy. 2023;2:60-70. DOI: https://doi.org/10.25259/IJSA_14_2023
Downloads
Published
How to Cite
Issue
Section
